Evidence map›Paper›PMID 33166296›Full record

ArticlePloS one2020

Diabetic polyneuropathy with/out neuropathic pain in Mali: A cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa.

Youssoufa Maiga, Salimata Diallo, Fatoumata Dite Nènè Konipo, Oumar Sangho, Modibo Sangaré, Seybou H Diallo, Saliou Mahamadou, Yann Péréon, Bernard Giumelli, Awa Coulibaly and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Youssoufa MaigaFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.ORCID 0000-0003-4102-8328
Salimata DialloDepartment of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Fatoumata Dite Nènè KonipoFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Oumar SanghoFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Modibo SangaréFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Seybou H DialloFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Saliou MahamadouDepartment of Diabetology, Gabriel Touré UHC, Bamako, Mali.
Yann PéréonReference Center of Neuromuscular Diseases Atlantique-Occitanie-Caraïbes, Hôtel-Dieu, UHC of Nantes, Nantes, France.
Bernard GiumelliFaculty of Dental Surgery, University of Nantes, Nantes, France.
Awa CoulibalyDepartment of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Mariam DaouDepartment of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Zoumana TraoréDepartment of Neurology, Hospital du Mali, Bamako, Mali.
Djeneba Sow SyllaFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Mohamed AlbakayeDepartment of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Cheick Oumar GuintoFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Madani OuologemFaculty of Dental Surgery, University of Nantes, Nantes, France.
Adama S SissokoFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Hamar A TraoréFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Souleymane Papa CoulibalyFaculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.
Philippe DamierFaculty of Medicine, University of Nantes, Nantes, France.
Nadine AttalINSERM U 98, CET, CHU Ambroise Paré, 92100 Boulogne-Billancourt, France.
Julien NizardLaboratory of Therapeutics (EA3826), Faculty of Medicine of Nantes, University of Nantes, Nantes, France.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNantes Université · FRInserm · FRMali-Folkecenter · ML

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiabetic polyneuropathy (DPN) with or without neuropathic pain is a frequent complication of diabetes. This work aimed to determine the prevalence of diabetic polyneuropathy, to describe its epidemiological aspects, and to analyze the therapeutic itinerary of patients with DPN.

methodsThis was a cross-sectional, descriptive study performed synchronously over six months at two major follow-up sites for patients with diabetes in Mali. DPN was diagnosed based on the Michigan Neuropathy Screening Instrument (MNSI). The neuropathic nature of the pain and the quality of life of patients were evaluated by the DN4 and the ED-5D scale, respectively. We used three (3) different questionnaires to collect data from patients (one at inclusion and another during the follow-up consultation) and from the caregivers of patients with DPN.

resultsWe included 252 patients with diabetes, and DPN was found to have a healthcare facility-based prevalence of 69.8% (176/252). The sex ratio was approximately three females for every male patient. The patients were mostly 31 to 60 years of age, 83% had type 2 diabetes, and 86.9% had neuropathic pain Approximately half of the patients (48.3%) had autonomic neuropathy and they reported moderate to intense pain, which was mainly described as a burning sensation. The patients exhibited impaired exteroceptive and proprioceptive sensations in 51.7% of cases. The patients smoked tobacco in 3.4% of cases, while 36.6% of the patients were obese and had dyslipidemia. The caregivers clearly indicated that appropriate medications were not readily accessible or available for their patients with DPN.

conclusionThe healthcare facility-based prevalence of DPN with or without neuropathic pain was high in our cohort. These inexpensive and easy-to-use tools (MNSI, DN4) can be used to adequately diagnose DPN in the African context. In Mali, screening and early treatment of patients at risk of DPN should allow for a reduction of the burden of the disease, while caregivers need to be adequately trained to manage DPN.

Indexed as

AdolescentAdultCross-Sectional StudiesDiabetic NeuropathiesFemaleHealth Care CostsHealth Knowledge, Attitudes, PracticeHumansMaleMaliMiddle AgedNeuralgiaQuality of LifeReferral and ConsultationRisk FactorsYoung Adult

Identifiers

PMID33166296
PMCPMC7652324
OpenAlexW3103963459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.